Association between COVID-19 illness severities with characteristics of the study sample
| Parameters | Xerostomia | Taste | Smell | ||||
|---|---|---|---|---|---|---|---|
| No | Yes | No | Yes | No | Yes | ||
| Age | Mean ± SD | 33.00 ± 12.46 | 38.70 ± 14.63 | 33.83 ± 12.69 | 39.99 ± 14.96 | 33.05 ± 12.43 | 39.16 ± 14.72 |
| p-value | < 0.0001* | < 0.0001* | < 0.0001* | ||||
| Gender: n (%) | Males | 101 (28.8%) | 250 (71.2%) | 169 (48.1%) | 182 (51.9%) | 134 (38.2%) | 217 (61.8%) |
| Females | 117 (24.6%) | 358 (75.4%) | 206 (43.4%) | 269 (56.6%) | 132 (27.8%) | 343 (72.2%) | |
| p-value | 0.182 | 0.173 | 0.002* | ||||
| Smoking: n (%) | No | 200 (28.6%) | 499 (71.4%) | 338 (48.4%) | 361 (51.6%) | 240 (34.3%) | 459 (65.7%) |
| Yes | 18 (14.2%) | 109 (85.8%) | 37 (29.1%) | 90 (70.9%) | 26 (20.5%) | 101 (79.5%) | |
| p-value | 0.001* | < 0.0001* | 0.002* | ||||
| Medical condition: n (%) | No | 185 (29.0%) | 454 (71.0%) | 314 (49.1%) | 325 (50.9%) | 229 (35.8%) | 410 (64.2%) |
| Yes | 33 (17.6%) | 154 (82.4%) | 61 (32.6%) | 126 (67.4%) | 37 (19.8%) | 150 (80.2%) | |
| p-value | 0.002* | < 0.0001* | < 0.0001* | ||||
| Long-term medication: n (%) | No | 172 (29.0%) | 421 (71.0%) | 295 (49.7%) | 298 (50.3%) | 216 (36.4%) | 377 (63.6%) |
| Yes | 46 (19.7%) | 187 (80.3%) | 80 (34.3%) | 153 (65.7%) | 50 (21.5%) | 183 (78.5%) | |
| p-value | 0.007* | < 0.0001* | < 0.0001* | ||||
| Severity of confirmed COVID-19 illness: n (%) | Mild | 120 (54.1%) | 102 (45.9%) | 162 (73.0%) | 60 (27.0%) | 124 (55.9%) | 98 (44.1%) |
| Moderate | 91 (21.3%) | 337 (78.7%) | 186 (43.5%) | 242 (56.5%) | 128 (29.9%) | 300 (70.1%) | |
| Severe | 7 (5.8%) | 114 (94.2%) | 25 (20.7%) | 96 (79.3%) | 14 (11.6%) | 107 (88.4%) | |
| Critical | 0 (0%) | 55 (100%) | 2 (3.6%) | 53 (96.4%) | 0 (0%) | 55 (100%) | |
| p-value | < 0.0001* | < 0.0001* | < 0.0001* | ||||
| Time passed since recovery: n (%) | < 6 months | 44 (44.4%) | 55 (55.6%) | 74 (74.7%) | 25 (25.3%) | 57 (57.6%) | 42 (42.4%) |
| 6 months | 91 (38.1%) | 148 (61.9%) | 137 (57.3%) | 102 (42.7%) | 93 (38.9%) | 146 (61.1%) | |
| 1 year | 27 (19.3%) | 113 (80.7%) | 58 (41.4%) | 82 (58.6%) | 41 (29.3%) | 99 (70.7%) | |
| 2 years | 40 (20.9%) | 151 (79.1%) | 74 (38.7%) | 117 (61.3%) | 46 (24.1%) | 145 (75.9%) | |
| 3 years | 16 (10.2%) | 141 (89.8%) | 32 (20.4%) | 125 (79.6%) | 29 (18.5%) | 128 (81.5%) | |
| p-value | < 0.0001* | < 0.0001* | < 0.0001* | ||||
* Statistically significant difference at p-value < 0.05